Citologija u dijagnozi raka jajnika by Vesna Ramljak et al.
33
REVIEW Libri Oncol., Vol. 43 (2015), No 1-3, 33 – 39
CYTOLOGY IN DIAGNOSIS OF OVARIAN CANCER
VESNA RAMLJAK, MERDITA AGAI MUHAXHIRI, IVA BOBUŠ KELČEC
Department for Cytology, University Hospital for Tumors, 
University Hospital Center Sestre milosrdnice, Zagreb, Croatia
Summary
Cytology has so far been underutilized as a modality for the primary diagnosis of ovarian cancer. Lately the outlook 
on fi ne needle aspiration cytology (FNAC) has greatly shifted. With the availability of modern techniques, USG and CT 
guided FNAC is becoming an optimum modality for the diagnosis of primary and metastatic ovarian neoplasms and evalu-
ation of recurrent malignant tumors, which consequently has a great impact on patient management. The most common 
indication for peritoneal washing cytology is staging or upstaging of ovarian carcinomas (First - look). Second - look proce-
dures are performed in patients previously treated by surgery, radiotherapy and/or chemotherapy to determine the pres-
ence of residual or recurrent ovarian cancer. In both procedures cytology has proven itself as a useful diagnostic method.
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CITOLOGIJA U DIJAGNOZI RAKA JAJNIKA
Sažetak
Kao dijagnostička metoda, citologija je do nedavno bila nedovoljno uključena u primarnu dijagnostiku raka jajnika. 
No, u novije se vrijeme stav prema aspiracijskoj citologiji tankom iglom jasno mijenja. Uz dostupne suvremene tehnologije, 
ultrazvukom i CT-om vođena citološka punkcija postaje optimalna metoda za dijagnozu primarnih i metastatskih novotvo-
rina jajnika, te za rano otkrivanje relapsa maligne bolesti. Time se citologija izravno upliće i u management liječenja pacijen-
ta. Citološka pretraga ispirka trbušne šupljine najčešće je indicirana u određivanju stadija karcinoma jajnika (tz v. „prvi po-
gled“). Zahvati tz v. „drugog pogleda“ izvode se na bolesnicima koji su prethodno tretirani kirurški, zračenjem i/ili kemote-
rapijom da bi se odredila ostatna bolest ili recidiv karcinoma jajnika. U oba navedena slučaja („prvi i drugi pogled“) 
citologija se dokazala kao korisna dijagnostička metoda. 
KLJUČNE RIJEČI: jajnik, aspiracijska citologija, peritonealna citologija, tumori jajnika, dijagnoza
INTRODUCTION
The very high mortality from ovarian cancer 
refl ects the dissemination of the tumor at the time 
of the diagnosis because of absence of symptoms 
in the early stage of the disease. The disease oc-
curs mainly in women past the age of 40 with me-
dian age of 58 at the time of diagnosis. The overall 
5 year survival rate is only 40% and is stage de-
pended.
Cytology has so far been underutilized as a 
modality for the primary diagnosis of ovarian can-
cer. This can be ascribed to (i) accuracy of imaging 
techniques like ultrasound and CT scan in detect-
ing malignancy and omental or peritoneal de-
posits, (ii) large variety of tumours are diffi  cult to 
subtype by cytology alone, (iii) fear of dispersing 
tumor cells into the peritoneal cavity, (iv) inexpe-
rience of cytopathologists in interpreting ovarian 
lesions and (v) the view among a substantial num-
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ber of clinicians that preoperative fi ne needle aspi-
ration cytology (FNAC) might delay an already 
indicated surgical treatment. There have been lim-
ited studies on FNAC in diagnoses of ovarian can-
cers (1).
However there are certain situations where 
cytology both FNA as well as exfoliative have an 
important role to play:
1)  In distinguishing non neoplastic cyst from 
true neoplasms of the ovary
2)  In detecting suspected pelvic recurrences 
in known cases of ovarian cancers
3)  In arriving at a primary diagnosis of ovar-
ian cancer in patients who are poor surgi-
cal risk
4)  Patients already having a disseminated 
disease at presentation
5)  In detected metastatic tumour deposits at 
unusual sites like cutaneous location in 
known cases of ovarian cancers
6)  Ascitic or pleural fl uid cytology for detec-
tion of malignant cells
7)  Peritoneal washings at the time of surgery 
to detect peritoneal deposits (1).
There is clear association between the stages 
and prognosis of ovarian malignant tumors. Since 
two-thirds of epithelial ovarian cancer cases pres-
ent at advanced stages and have a low 5-year sur-
vival rate, early evaluation of ovarian lesions is 
very important (2,3). Those women diagnosed 
with disease confi ned to ovary often require less 
aggressive surgical intervention, may not require 
chemotherapy and have an overall 5-year survival 
rate of approximating 90% (2).
OBTAINING THE SPECIMEN
Taking cytological matherial should always 
be performed under radiologic guidance, prefera-
bly ultrasound. Transvaginal route is a favoured 
approach. Transabdominal, transrectal, laparo-
scopic and aspiration at the time of laparotomy 
are some of the other approaches possible. Trans-
abdominal approach is suited for large masses 
with omental deposits. The method used depends 
on the size of the lesion, its location, and the re-
sources available to the person performing the as-
piration (4). Complications are uncommon. Al-
though common wisdom holds that puncture of a 
malignant tumor can cause seeding of the perito-
neal cavity, documented cases are actually rare 
(5). If any ultrasound features are worrisome, the 
physician will usually forego aspiration and rec-
ommend surgery. Aspiratin of suspicious ovaran 
masses should be avoided, except to confi rm ma-
lignancy in patient with inoperable or metastatic 
disease.
PREPARING THE SPECIMEN 
AND REPORTING RESULTS
Specimens are usually cyst fl uids. Standard 
method are used in preparation. A portion of fresh 
fl uid can be used to measure the level of E2 or tu-
mor-associated antigens cancer antigen 125 (CA-
125), carcinoembryonic antigen (CEA), and al-
phafetoprotein (AFP). Elevated levels are typical 
of some ovarian lesions and can be useful adjunct 
to cytologic examination (6,7). FNA of the ovary is 
generally reserved for small, incidental masses 
that appear benign on sonographic or laparoscop-
icexaminarion (1-3). Incidental ovarian cysts are 
often discovered in women with infertility or dur-
ing pregnancy (4). Aspiration cytology, in combi-
nation with a benign ultrasound appearance, is 
used to reassure the patient that an oophorectomy 
is not necessary (5). In some laboratories, estradiol 
(E2) levels in the fl uid are also measured because 
these are usually elevated in folicle-derived cysts 
but not in epithelial lesions (6,7). Thus, ultrasound, 
cytology and E2 levels can form an eff ective „tri-
ple test“ for distinguishing benign from malignant 
ovarian cyst.
Specimens that are virtually acellular are best 
termed non-diagnostic (8,9). The percentage of 
FNAs of the ovary that are non-diagnostic ranges 
widely, from a low of 13% to a high of 72% (4,10).
This variation is likely related to the type of lesion 
selected for aspiration and the defi nition of a non-
diagnostic specimen. The  cytology report should 
state that malignant cells are either absent(no ma-
lignant cells identifi ed) or present (positive for 
malignant cells). If the fi nding is equivocal, the 
report should state either that atypical or suspi-
cious cells are present. Benign ovarian FNA re-
sults fall into two broad categories: 1. Follicular or 
lutein cysts, and 2.epithelial cyst. This has signifi -
cant clinical relevance because surgery is unneces-
sary for follicle-derived cysts, which usually re-
gress over time. Surgery may be indicated, how-
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ever, for a benign-appearing epithelial cyst, 
particulary if the sonographic fi ndings are worri-
some (11).
BENIGN TUMOR-LIKE LESIONS 
OF THE OVARY
Non-neoplastic cysts
Benign ovarian cysts are common; the major-
ity are discovered incidentally by USG laparosco-
py, or laparotomy. The most common are the so-
called functional cysts and the second major cate-
gorie are nonfunctional cysts derived from ovarian 
surface epithelium or endometriosis. Precise clas-
sifi cation by cytologic examination is not always 
possible, particulary when only cyst contents (fl u-
id and macrophages) are obtained (12). One of the 
most common, cystic lesions of the ovary, they 
arise from an ovarian follicle and are not neoplas-
tic but rather physiologic. Follicle cysts can be 
solitary or multiple and range in size up to 8cm or 
more in diametar. Because follicle cyst appear be-
nign sonographically and laparoscopically, they 
are managed conservatively, with an eye on pre-
serving the ovary. FNA is commonly used as a 
minimally invasive method for sampling the le-
sion and confi rming it is in fact benign. When cili-
ated or mucinous epithelium is identifi ed, the cyst 
is of surface epithelial origin and not a follicle cyst. 
E2 levels in cyst fl uid as measured by radioimmu-
noassay are helpful; elevated E2 concentracion 
correlates strongly with cysts of folicular origin 
(10,13). Eighty-one percent to 90% of follicle cysts 
have an e2 content greater than 20nmol/L, and in 
97% to 99% of nonfollicular cysts the E2 content is 
less than 20 nmol/L.  The other non-neoplastic 
cysts are corpus luteum cyst, endometriotic cyst, 
simple ovarian, paraovarian and paratubal cyst 
(7,14).
Hydrosalpinx, a complication of salpingitis, 
presents as large cystic adnexal mass. The dis-
tended fallopian tube is fi lled with clear fl uid and 
is lined by ciliated epithelium. These fi ndings are 
identical to those seen with serous ovarian and 
parovarian cysts (15).
Tubo-ovarian abscess is an advanced compli-
cation of acute salpingitis, known clinically as pel-
vic infl amatory disease. Most cases resultfrom an 
ascending infection of the lower genital tract by 
sexually transmited pathogens, of which the most 
common are Neisseria gonorrhoeae, Chlamydia 
trachomatis, and Mycoplasma genitalium (15).
SCOPE OF CYTOMORPHOLOGY 
IN DIAGNOSIS OF COMMON MALIGNANT 
OVARIAN NEOPLASMS
Borderline tumours of  ovary
Borderline serous & mucinous neoplasms are 
diffi  cult to diff erentiate from malignant counter-
part as invasion cannot be documented on cytolo-
gy. They usually present as highly cellular smears 
with nuclear features ranging from bland to high-
ly atypical. A defi nitive diagnosis of a borderline 
ovarian surface epithelial tumour is not possible 
on cytologic material (1).
Malignant tumours of  ovary
The cytologic diagnostic accuracy for ovarian 
carcinoma is in the range of 90-95% tumours. A 
negative diagnosis in a suspected case does not 
rule out malignancy and should warrant a repeat 
procedure. Subtyping is relatively easier in the 
low and intermediate grade tumours, but is not 
possible in the high grade varieties (1).  The prin-
cipal groups of ovarian carcinomas are: Serous 
carcinomas, Mucin-producing carcinomas and 
Endometrioid carcinomas. Direct aspiration from 
ovarian carcinomas are, as a rule, richer in cells 
than are aspirates from benign epithelial tumors. 
The cytologic recognition of a malignant tumor is 
usually not diffi  cult. Even in well-diff erentiated 
types of carcinoma, the smeared aspirate contains 
approximately spherical (papilary)groups of can-
cer cells, often with characteristic nuclear features, 
such as enlargement andhyperchromasia, large 
nucleoli, and thickening of the nuclear membrane. 
In serous adenocarcinoma, the cells may form a 
monolayer, but such a fi nding is insuffi  cient for a 
reliable distinction between a serous and endome-
trioid carcinoma. Psammoma bodies are rarely 
seen in direct aspirates. Mucinous ovarian carci-
noma may be recognized by the presence of mu-
cus-producing columnar cells embedded in mass-
es of mucin. Clear cell adenocarcinomas may re-
semble clear cell adenocarcinoma of the kidney. 
The germ cell tumours (GCT) constitute the ma-
jority of ovarian masses in the pediatric age group. 
Most GCTs can be reliably diagnosed and sub-
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typed on FNAC, in conjunction with tumour 
marker levels and immunocytochemistry. Endo-
metrioid tumours display features like those of 
the endometrial counterpart, but may be diffi  cult 
to distinguish from serous cytadenocarcinomas. 
Malignant mixed mullerain tumours can only be 
suspected when both epithelial and sarcomatous 
component are aspirated, otherwise it may be 
classifi ed as an adenocarcinoma. Granulosa cell 
tumour can be diagnosed on FNA in the presence 
of acinar like structures with central reddish-vio-
let bodies called as Callexner bodies and cells with 
nuclear grooves. Aspirates from stromal tumours 
of ovary may yield very sparse material and may 
be diffi  cult to diagnose on FNAC. 
The accuracy of aspiration biopsy cytologic 
diagnosis in patient with ovarian enlargement or 
cancer was reported by Kjellgren and Angstrom 
(1971, 1979), Geier  et all (1975), Nadji et all (1979) 
and Geier and Strecker (1981). In these reports, 
ovarian cancer was accurately identifi ed in ap-
proximately 85% to 9o% of cases. The proportion 
of false-positive cytologic reports in histologically 
benign lesions varied from 0% to about 5%. None 
of these authors reported on spread of tumor cells 
after the procedure (16).
In about 20% to 30% of patients with ad-
vanced ovarian carcinoma, regardless of histolog-
ic type, malignant cells may be observed incervi-
covaginal preparations and occasionally in endo-
cervical and endometrial aspirates. (Jobo et all) 
Conversely, the presence of ovarian cancer cells in 
cervicovaginal smears usually, but not always, in-
dicates advanced disease. The cancer cells may be 
derived from a primary tumor, via the fallopian 
tubes and the endometrial cavity, but may also re-
fl ect metastatic foci either within the endometrial 
cavity or in the vagina. When seen in cervicovagi-
nal smears or in endometrial aspirates, the tumor 
cells of nearly all ovarian cancers form clusters, 
often of papillary confi guration, made up of large 
malignant cells with prominent, large nuclei, con-
taining multiple, often large, irregular nucleoli 
(16, 15).
Psammoma bodies are commonly found in 
serous carcinoma of the ovary, less commonly in 
the bordeline serous tumors, very rarely in endo-
metrioid carcinomas,and practically never in mu-
cous tumors. Endosalpingiosis is the most impor-
tant entity in the diff erential diagnosis of serous 
ovarian carcinomas with which it shares the pres-
ence of numerous psammoma bodies in cervico-
vaginal smears and other cytologic preparation. 
The presence of psammoma bodies in a cervico-
vaginal preparation or in endocervical or endome-
trial aspiration, particulary in the absence of an 
intrauterine contraceptive device, calls for a thor-
ough investigation of the female genital tract to 
rule out of malignant tumor, most likely of ovari-
an origin (16).
Role of  immunocytochemistry
Most of the surface epithelial malignancies 
can be diagnosed without resort to immunocyto-
chemistry. Immunocytochemistry for inhibin in 
Figure 2. Immunocytochemistry, Ca125
Figure 1. Immunocytochemistry, CK 7
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conjunction with Ber EP4, CK 7 and CA-125 may 
help in diff erentiating follicular cells in nonneo-
plastic cyst aspirates from epithelial proliferations 
in neoplastic masses. Metastatic tumours may also 
be distinguished from primary using animmuno-
cytochemistry panel. Antibodiesagainst PLAP, 
AFP and beta HCG may help in classifying germ 
cell tumours (1).
INTRAOPERATIVE FNA FROM IN SITU 
MASS LESIONS DURING OPERATION
As a diagnostic tool, intraoperative cytology 
off ers simplicity, speed, accuracy, excellent cellu-
lar detail and thus several adventages over con-
ventional frozen section techniques. It provides 
accurate results in minutes while the patient is un-
der anesthesia. The surgeon often needs micro-
scopic confi rmation of the clinical diagnosis be-
fore undertaking major resection. Microscopic di-
agnosis is required for planning subsequent 
menagement of irresectable lesions. Intraopera-
tive cytology permits microscopic evaluation of 
lesions that are not suitable for surgical biopsy 
and can be used as an alternative to surgical bi-
opsy in selected case. Also, FNAC permits more 
accurate sampling from deeply seated lesions. 
 Unfortunately, it is not being used to its fullest 
 extend. Percutaneous fi ne needle aspiration is as-
sociated with advanced disease and is highly spe-
cifi c in predicting unresectability of some adeno-
carcinomas, resulting in decreased survival. 
METASTATIC TUMORS
The most common tumors that metastasize 
to the ovaries arise in the urogenital tract, colon, 
stomach and breast. Approximately 15% to 20% of 
bilateral ovarian malignancies are metastatic. Tu-
mors that occur as multiple nodules on the ovari-
an surface are likely to be metastatic. Krukenberg 
tumors are characterized by mucin-fi lled signet 
ring-shaped cells metastatic to the ovary (17). The 
majority of these tumors arise in the stomach, but 
tumors of the colon, appendix, andbreast also 
cause this patt ern of spread. 
In many cases, distinguishing between a pri-
mary ovarian carcinoma and a metastasis is im-
possible by cytomorphology alone. Measuring the 
concentration of tumor-associated antigens in cyst 
fl uid is useful;unlike ovarian carcinomas, meta-
static colon cancers have a high CEA level com-
bined with a low CA-125 level (7).
PERITONEAL CYTOLOGY
Peritoneal dissemination of malignant cells is 
a signifi cant prognostic variable in gastric and gy-
necologic malignancies which means that perito-
neal cytology is clinically useful in both of them 
(Figure 3,4,5).  FIGO incorporated the results of 
peritoneal washing cytology into the staging clas-
sifi cation of ovarian cancer in 1975. Cytologic 
Figure 3. Ca serosum, Peritoneal washing, Psamoma body 
(MGGx400)
Figure 4 Ca serosum, peritoneal washing (MGGx200)
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CONCLUSION
Cytology has so far been underutilized as a 
modality for the primary diagnosis of ovarian can-
cer. This can be ascribed to (i) accuracy of imaging 
techniques like ultrasound and CT scan in det-
ecting malignancy and omental or peritoneal de-
posits, (ii) large variety of tumours are diffi  cult to 
subtype by cytology alone, (iii) fear of dispersing 
tumour cells into the peritoneal cavity, (iv) inex-
perience of cytopathologists in interpreting ovari-
an lesions and (v) the view among a substantial 
number of clinicians that preoperative fi ne needle 
aspiration cytology (FNAC) might delay an al-
ready indicated surgical treatment. 
But lately the outlook on FNAC has greatly 
shifted. With the availability of modern techni-
ques, USG and CT guided FNAC is becoming an 
optimum modality for the diagnosis of primary 
and metastatic ovarian neoplasms and evaluation 
of reccurent malignant tumors, which consequen-
tly has a great impact on patient management. 
The most common indication for peritoneal wash-
ing cytology is staging or upstaging of ovarian 
carcinomas (First - look). Second - look procedures 
are performed in patients previously treated by 
surgery, radiotherapy and/or chemotherapy to 
determine the presence of residual or recurrent 
ovarian cancer. In both procedures cytology has 
proven itself as a useful diagnostic method.
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